Technology
Health
Pharmaceutical
Genprex
$0.929876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$0.92
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.01 (1.10%) As of 11:28 AM EDT today
+$0.01 (1.10%) Today
Why Robinhood?
You can buy or sell Genprex and other stocks, options, ETFs, and crypto commission-free!
About GNPX
Genprex, Inc. Common Stock, also called Genprex, is a clinical stage gene therapy company, which engages in the development of novel proprietary technology platform for the treatment of cancer. Read More It develops the Oncoprex immunogene therapy which targets the non-small cell lung cancer and other solid tumors. The company was founded by J. Rodney Varner in April 2009 and is headquartered in Austin, TX.
Employees
7
Headquarters
Austin, Texas
Founded
2009
Market Cap
14.42M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
27.98K
High Today
$0.92
Low Today
$0.92
Open Price
$0.92
Volume
336.00
52 Week High
$2.76
52 Week Low
$0.641
Collections
Technology
Health
Pharmaceutical
Therapy
Cancer Prevention
Medical
2018 IPO
US
Price Paid on Robinhood
73% Lower
Right Now
52 Week Low
$0.95
Average Price Paid
$3.44
52 Week High
$19.45